Wednesday, 15 November 2017

General Medical Council to look into UKAD evidence, but not jiffy bag

http://ift.tt/2zG9sCz

The infamous medical package that has sparked so much controversy surrounding Bradley Wiggins, Team Sky, and British Cycling looks set to remain a mystery. After closing its 14-month investigation, UK Anti-Doping (UKAD) has passed on evidence ‘of interest’ to the General Medical Council (GMC), though Cyclingnews understands that the jiffy bag will not come under investigation from the regulatory body.

UKAD issued a statement on Wednesday outlining that no anti-doping charges will be brought against Wiggins, Sky, or British Cycling due to a lack of evidence surrounding the medical product that was couriered from the UK to France by a British Cycling employee and administered to Wiggins at the 2011 Critérium du Dauphiné. The organisation found it 'impossible' to substantiate or refute claims it was the legal decongestant fluimucil, nor allegations that it was the corticosteroid triamcinolone, banned in competition.

In its statement on Wednesday, UKAD explained that it “became aware of information that it considered to be of possible interest to the General Medical Council” and that it has “shared that information with the GMC, and will continue to liaise with the GMC as appropriate in relation to that information”.

ADVERTISEMENT
advertisement

The GMC confirmed that it is looking into the information supplied.

A spokesperson said: “UKAD have made us aware of concerns and we are looking into these. However, we are not able to comment further on this matter.”

Shortcomings in the keeping of medical records on the part of both Team Sky and British Cycling drew heavy criticism during a parliamentary committee and eventually led the UKAD investigation to a dead end, with the organisation’s chief executive Nicole Sapstead expressing “serious concern".

You can read more at Cyclingnews.com



via Cyclingnews Latest News http://ift.tt/2zHJiiI

No comments:

Post a Comment